Professor in Pediatrics, Northwestern University Medical School
Medical Genetics
Dr. Joel M. Charrow, MD
|
|
Give Review
Joel Charrow works in the field of Medical Genetics. He researched medicine at Icahn School of Medicine at Mount Sinai. Icahn School of Medicine at Mount Sinai is ranked 20 in research and 62 in primary care medicine He received 4 awards: "America's Top Doctors", "Chicago Magazine: Top Doctors", "Super Doctor" and "Fellow (FAAP)". Dr. Joel M. Charrow is a published physician. He published 100 publications, including: 'Gaucher disease: recommendations on diagnosis, evaluation, and monitoring.' Joel Charrow accepts Medicare payments and is registered with Medicare.gov.
Publications
- Recommendations for the use of eliglustat in the treatment of adults with Gaucher disease type 1 in the United States.
- Strabismus in patients with neurofibromatosis type 1-associated optic pathway glioma.
- Antiproteinuric therapy and Fabry nephropathy: factors associated with preserved kidney function during agalsidase-beta therapy.
- Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease.
- Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease.
- Storage and use of Newborn Screening Blood Specimens for Research: Assessing Public Opinion in Illinois.
- Gender as a disease modifier in neurofibromatosis type 1 optic pathway glioma.
- Erratum to: Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment.
- Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment.
- Algorithm for the Early Diagnosis and Treatment of Patients with Cross Reactive Immunologic Material-Negative Classic Infantile Pompe Disease: A Step towards Improving...
- Gustatory flushing (auriculotemporal nerve syndrome) in children with neurofibromatosis type 1 and facial plexiform neurofibromas.
- Fanconi-Bickel syndrome: report of life history and successful pregnancy in an affected patient.
- Growth hormone excess in children with neurofibromatosis type 1-associated and sporadic optic pathway tumors.
- Episodic myoglobinuria in a primary gamma-sarcoglycanopathy.
- Neurofibromatosis type 1 and high-grade tumors of the central nervous system.
- Population-based Tay-Sachs screening among Ashkenazi Jewish young adults in the 21st century: Hexosaminidase A enzyme assay is essential for accurate testing.
- A 14-year-old boy with pain in hands and feet.
- Vitamin B12 status, methylmalonic acidemia, and bacterial overgrowth in short bowel syndrome.
- Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1.
- Neuroimaging findings in children with rare or novel de novo chromosomal anomalies.
- Prevalence of type 1 Gaucher disease in the United States.
- A newborn girl with hypotonia and respiratory failure.
- A 5-year-old girl with developmental delay.
- Documented transient third-degree atrioventricular block and asystole in a child with familial dysautonomia.
- Correction of enzyme levels with allogeneic hematopoeitic progenitor cell transplantation in Niemann-Pick type B.
- A 3 year old with obesity and hypotonia. Prader-Willi syndrome.
- Different colored eyes. Waardenburg syndrome.
- Missing fingers and toes. Amnion rupture sequence.
- A newborn with multiple congenital anomalies. Trisomy 18.
- Case challenges in genetics.
- Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease.
- Fabry disease: baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry.
- The effect of enzyme replacement therapy on bone crisis and bone pain in patients with type 1 Gaucher disease.
- Development of a newborn screening follow-up algorithm for the diagnosis of isobutyryl-CoA dehydrogenase deficiency.
- Orbital optic nerve gliomas in children with neurofibromatosis type 1.
- A 1-year-old girl with "puffy feet".
- An 11-year-old girl with multiple hyperpigmented macules.
- Knowledge and attitudes toward a free education and Ashkenazi Jewish carrier testing program.
- A 15-month-old boy with macrocephaly.
- An 11-day-old boy with lethargy, poor feeding, vomiting. Maple syrup urine disease.
- Guidance on the use of miglustat for treating patients with type 1 Gaucher disease.
- A 4-year-old boy with fever. Achondroplasia.
- A 22-month-old boy with slow development.
- Gaucher disease and cancer incidence: a study from the Gaucher Registry.
- Individualization of long-term enzyme replacement therapy for Gaucher disease.
- A young girl with abnormal hands, symptoms of short stature. Trichorhinophalangeal syndrome.
- The genetics of tethered cord syndrome.
- Late-onset optic pathway tumors in children with neurofibromatosis 1.
- Neurofibromatosis-1 in childhood.
- Ashkenazi Jewish genetic disorders.
- Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patients.
- Knowledge without truth: screening for complications of neurofibromatosis type 1 in childhood.
- Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations.
- Paediatric non-neuronopathic Gaucher disease: recommendations for treatment and monitoring.
- Pediatric non-neuronopathic Gaucher disease: presentation, diagnosis and assessment. Consensus statements.
- Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome.
- Segmental neurofibromatosis in childhood.
- Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher Registry.
- Early speech delay and hepatitis as presenting signs of homocystinuria.
- Comments on neurofibromatosis 1 and optic pathway tumors.
- Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial.
- The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease.
- Carboplatin therapy for optic pathway tumors in children with neurofibromatosis type-1.
- Neural tube defects and the 13q deletion syndrome: evidence for a critical region in 13q33-34.
- Myelocystocele-cloacal exstrophy in a pedigree with a mitochondrial 12S rRNA mutation, aminoglycoside-induced deafness, pigmentary disturbances, and spinal anomalies.
- Neural crest anomaly syndromes in children with spina bifida.
- Intracranial gliomas in neurofibromatosis type 1.
- Gaucher disease: recommendations on diagnosis, evaluation, and monitoring.
- Myelomeningocele and Waardenburg syndrome (type 3) in patients with interstitial deletions of 2q35 and the PAX3 gene: possible digenic inheritance of a neural tube def...
- Neurofibromatosis type I and precocious puberty: beyond the chasm.
- Acceleration of retarded growth in children with Gaucher disease after treatment with alglucerase.
- Black clouds. Work load, sleep, and resident reputation.
- Surgical treatment of patients with lobar holoprosencephaly: a personal note.
- Autosomal dominant multiple café-au-lait spots and neurofibromatosis-1: evidence of non-linkage.
- Carboplatin-induced regression of an optic pathway tumor in a child with neurofibromatosis.
- Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study.
- Precocious puberty in children with neurofibromatosis type 1.
- Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history.
- Prenatal monitoring and genetic counseling in a 47, XXX female with the oro-facial digital syndrome-type 1.
- Duplication 3p syndrome: report of a new case and review of the literature.
- Apparently normal extracellular acidic alpha-mannosidase in fibroblast cultures from patients with mannosidosis.
- Partial trisomy 14 (q23 leads to qter) via segregation of a 14/X translocation.
- Pedal hemangiomas in Turner syndrome.
- Translocations in Prader-Willi syndrome.
- The Jansen type of metaphyseal chondrodysplasia: confirmation of dominant inheritance and review of radiographic manifestations in the newborn and adult.
- Prenatal diagnosis and management of endocrine and metabolic disorders.
- Uncombable hair (pili trianguli et canaliculi): evidence for dominant inheritance with complete penetrance based on scanning electron microscopy.
- Late onset GM2 gangliosidosis: an alpha-locus genetic compound with near normal hexosaminidase activity.
- Cardiomyopathy and skeletal myopathy in an unusual variant of GM1 gangliosidosis.
- Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
- Optic gliomas in children with neurofibromatosis type 1.
- Biochemical abnormalities in rhizomelic chondrodysplasia punctata.
- When is a test result abnormal? Defining limits and risks.
- Neurofibromatosis type 1 in childhood.
- Autosomal recessive cerebellar hypoplasia and endosteal sclerosis: a newly recognized syndrome.
- Nonmendelian inheritance.
- Emergence of optic pathway gliomas in children with neurofibromatosis type 1 after normal neuroimaging results.
- Potato craving secondary to potassium wasting in Bartter''s syndrome.
- Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry.
Schools
Mount Sinai School Of Medicine Of New York University
Children39s Memorial Hospital
Doctors Specialties
- Clinical Biochemical Genetics
- Clinical Genetics
- Pediatrics
- Medical Genetics
Accepted Insurances
Awards
- America's Top Doctors
- Chicago Magazine: Top Doctors
- Super Doctor
- Fellow (FAAP)
Education
-
McGaw Medical Center of Northwestern University -
Icahn School of Medicine at Mount Sinai
Hospital
-
Lurie Children's Hospital of Chicago -
Northwestern Memorial Hospital -
Ann & Robert H. Lurie Children?
Drug Facts
| NPI NUMBER | 1962466375 | |
| NPPES Provider LastName | CHARROW | |
| NPPES Provider FirstName | JOEL | |
| NPPES Provider ZIPCode | 606143363 | |
| NPPES Provider State | IL | |
| Specialty Description | Pediatric Medicine | |
| Total Claim Count | 29.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1962466375 |
| Last Name Of The Provider | CHARROW |
| First Name Of The Provider | JOEL |
| View All |
Similar Doctors
|
|
Dr. Eugene Pergament, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brad Angle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan C. Echiverri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barbara K. Burton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allen L. Horwitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aparna Modi, MD |
|
|
Dr. Margeaux C. Le, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tracy A. Winger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vyta Ben Barak, MD |
|
|
Dr. Nirmla Verma, MD |
|
|
Dr. Marion S. Verp, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William B. Dobyns, MD |
|
|
Dr. Jeffrey S. Dungan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yanming Zhang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael A. Niaki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Lama T. Eldahdah
This Doctor is OpenDoctor Recommended.
|